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INTRODUCTION
Diabetes mellitus is a common chronic metabolic syndrome
characterised by hyperglycemia as a cardinal biochemical feature.
It is group of disorders having varying etiology and pathogenesis
leading to the impairment of glucose tolerance characterised by
hyperglycemia, glycosuria and polyuria.
Diabetes mellitus is the most common non communicable
disease which shortens lifespan by 15 years and it is a leading
cause of blindness and end stage renal disease. The factors that
contribute to hyperglycemia include decreased insulin secretion,
decreased insulin action and gluconeogenesis.
          Diabetes mellitus can be treated and complications can be
avoided or delayed by dietary management, lifestyle management,
medication and regular screening and treatment for complications.
INCIDENCE OF DIABETES MELLITUS :( 1)
      Incidence is increasing alarmingly affecting 3% of world
population. Globally, an estimated 422 million adults were living
with diabetes in 2014, compared to 108 million in 1980. The global
prevalence (age-standardized) of diabetes has nearly doubled since
1980, rising from 4.7% to 8.5% in the adult population. This
reflects an increase in associated risk factors such as being
overweight or obese.
In 2014, 8.5% of adults aged 18 years and older had diabetes.
In 2015, diabetes was the direct cause of 1.6 million deaths and in
2012 high blood glucose was the cause of another 2.2 million
deaths. WHO projects that diabetes will be the seventh leading
cause of death in 2030. Healthy diet, regular physical activity,
maintaining a normal body weight and avoiding tobacco use are
ways to prevent or delay the onset of type 2diabetes.
INCIDENCE OF DIABETES MELLITUS IN CHILDREN (2)
The most common cause of diabetes in children is due to an
absolute deficiency of insulin secretion because of destruction of
the beta cells of the pancreatic islets. Diabetes in children and
adolescence affects growth and puberty.
In 2001, 4958 of 3.3 million youth were diagnosed with type
1 diabetes for a prevalence of 1.48 per 1000. In 2009, 6666 of 3.4
million youth were diagnosed with type 1 diabetes for a prevalence
of 1.93 per 1000.
In 2001, 588 of 1.7 million youth were diagnosed with type 2
diabetes for a prevalence of 0.34 per 1000. In 2009, 819 of 1.8
million were diagnosed with type 2 diabetes for a prevalence of
0.46 per 1000.
CLASSIFICATION OF DIABETES MELLITUS
DM classification based on American Diabetes association(3)
1. Type 1 diabetes (?-cell destruction causing insulin
deficiency)
2. Type 2 diabetes (defect in insulin secretion on the
background of insulin resistance)
3. Gestational diabetes mellitus (diabetes diagnosed in
pregnancy)
4. Specific types of diabetes due to other causes
? Monogenic diabetes syndromes( maturity-onset diabetes of
the young [MODY])
? Diseases of the exocrine pancreas : Chronic pancreatitis,
Pancreatectomy, Neoplasia, Cystic fibrosis,
Hemochromatosis, Fibrocalculous pancreatopathy.
? Drug induced diabetes (Glucocorticoids, Thyroid hormone,?-
Adrenergic agonists)
? Infections  (Cytomegalovirus, Coxsackievirus B, Congenital
rubella)
? Genetic Syndromes Associated with Diabetes (Down
syndrome, Klinefelter syndrome, Turner syndrome).
TYPE 2 DIABETES IN CHILDREN AND ADOLESCENTS
Type 2 diabetes mellitus is emerging as a new clinical
problem within pediatric practice. Recent reports indicate an
increasing prevalence of type 2 diabetes mellitus in children and
adolescents around the world in all ethnicities.
Reinehr T et al study (4) described, type 2 diabetes mellitus
has been thought to be a rare occurrence in children and
adolescents 30 years ago. However, in the mid-1990s, investigators
began to observe an increasing incidence of type 2 diabetes mellitus
worldwide. This observation followed a striking increase in both
the prevalence and the degree of obesity in children and
adolescents.
Type 2 Diabetes Mellitus was considered a rarity in
adolescence until recently. However, in recent decades, many
authors have been reporting an increase in the incidence of diabetes
in adolescents with similar characteristics to those of DM 2 in
adults. The increase in the incidence of T2DM in young people was
observed among those between 15 and 24 years old. The increase in
the prevalence of obesity in adolescence explains the increase of
DM2 in young populations.
T2DM IN INDIAN CHILDREN AND ADOLESCENTS
The prevalence of T2DM in children in India is increasing
and during the last ten years it was shown by the following studies.
Study conducted by Ramachandran, et al (5) reported T2DM
in 18    children (13 girls and 5 boys) out of 257 aged less than   15
years. Nine of them were obese and without any symptoms and was
detected on screening which was done due to strong family history
of DM and/or due to obesity.
Bhatia, et al (6) conducted study in which of 160 children,
12% of children less than 18years of age had T2DM was diagnosed.
Hence in India we need Screening for T2DM in children
seems meaningful especially in high risk groups such as children
and adolescents with obesity, parents with type 2 diabetes mellitus,
and clinical features of insulin resistance (Hypertension,
Dyslipidemia, PCOS and Acanthosis nigricans).
PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS IN
CHILDREN AND ADOLESCENTS (4)
Type 2 diabetes mellitus is a disorder with heterogeneous
etiology such as social, behavioral, and environmental risk factors.
These factors unmask the effects of genetic susceptibility which
plays a major role in Type 2 DM.
Glucose homeostasis
It depends on the balance between insulin secretion and
insulin action. The insulin resistance to glucose uptake is a
characteristic finding in patients with type 2 diabetes mellitus. The
evolution from normal to impaired glucose tolerance (IGT) is
associated with a worsening of insulin resistance.
Impaired glucose tolerance is an intermediate stage in the
natural history of type 2 diabetes mellitus. IGT is a predictor of the
risk of developing diabetes mellitus. Insulin resistance alone is not
sufficient for development of diabetes but also inadequate insulin
secretion. It has been proposed that hyperglycaemia may worsen
both insulin resistance and insulin secretory function and thus
enhancing the transition from impaired glucose tolerance to
diabetes mellitus.
INSULIN RESISTANCE
Resistance to the action of insulin in the liver leads to an
increase of hepatic glucose production. During the initial phase, the
increase in glycemia levels is compensated by an increase in insulin
secretion, but as the process persists for prolonged periods a
glucotoxic effect will come. A glucotoxic effect is defined as an
increased resistance to the effects of insulin and a decrease in beta
cell function due to chronic hyperglycemia.
Disorders associated with insulin resistance and obesity:  (7)
1. Acanthosis nigricans
2. Polycystic Ovarian Syndrome
1. Acanthosis nigricans:
Acanthosis nigricans is a cutaneous finding characterized by
velvety hyperpigmented patches most prominent in the
intertrigenous area and is present in up to 90% of children with
T2DM. It is recognized more frequently in darker-skinned obese
individuals.
Histology of Acanthosis nigricans
It is characterized by papillomatosis and hyperkeratosis which is a
darkening due to the thickening of the superficial epithelium which
contains keratin. There is hyperplasia of all elements of the dermis and
epidermis which suggests stimulation by a local growth factor. Increased
IGF-1 and epidermal growth factor (EGF) are implicated in this
process.(8)
Picture of Acanthosis nigricans in axilla
Polycystic Ovarian Syndrome (PCOS) (9)
PCOS is a reproductive disorder characterized by
hyperandrogenism and chronic anovulation. PCOS is a disorder of
hormone function affecting 5-8% of women of reproductive age . It
is characterized by the triad of oligoovulation or anovulation,
clinical or biochemical hyperandrogenism, and ovaries with a
polycystic morphology on ultrasound examination (?12 follicles in
1 ovary and/or ovarian volume >10 ml/mm3). Abnormalities
commonly associated with PCOS include obesity, insulin
resistance, and the metabolic syndrome. Insulin resistance is greater
and more prevalent among women with PCOS. PCOS is associated
with an increased prevalence of insulin resistance and type 2
diabetes in adolescent girls.
Picture of PCOS in Ultrasonogram
RISK FACTORS FOR T2DM
1.Ethinicity
2.Family History
3.Puberty
4.Obesity
5.Low birth weight
6.History of GDM in mother
1. Ethnicity
According to survey conducted by Health Survey for
England (HSE) (10), the risk group for T2DM are Indo-Asians.
Indo-Asians who have migrated to western societies as well as
those living in urban areas of the Indian subcontinent have higher
prevalence of T2DM.
Yajnik CS, Lubree HG, Rege SS et al study (11) described,
Indian babies are usually lighter at birth but their fat mass is
preserved and have tendency to truncal or central adiposity even
during intrauterine development. They also have Higher umbilical
cord insulin concentrations have been demonstrated, suggesting that
an insulin-resistant phenotype is present at birth in Indian babies.
By 8 years of age, these lower birth weight Indian babies have
abnormalities in systolic blood pressure, fasting plasma insulin,
subscapular/triceps skinfold ratios and total LDL cholesterol
concentrations and are at risk for diabetes.
2. Family history
Haines L, Wan KC, Lynn R, Barrett TG, Shield JPH et al
study (12) shows the great majority of children with T2DM have a
strong family history of T2DM. 74–100% had a first- or second
degree relative with T2DM.
Diabetes in the parent or other relative may not be recognized
until the child is diagnosed. The high frequency of relatives with
T2DM demonstrate the strong hereditary (likely multigenic)
component to the disease.
Families will also share the same dietary habits as well as
approaches to physical activity. UK data suggest that 84% of
children diagnosed with T2DM have a family history. Family
history is also important among children with obesity. 85%, of
children with T2DM are obese or overweight at presentation.
3. Puberty
Arslanian SA et al study (13) described a major role of
puberty in the development of type 2 diabetes mellitus in children.
During puberty, there is increased resistance to the action of
insulin, resulting in hyperinsulinemia. After puberty, basal and
stimulated insulin responses decline and there is normalization
from IGT to normal glucose tolerance in children and adolescents
with impaired glucose tolerance. This normalization has been
attributed to changes of insulin resistance at end of puberty.
Increased growth hormone secretion in puberty is also
responsible for the insulin resistance. Growth hormone acts as a
lipase stimulant, provoking an increase in free fatty acid
oxidization, which results in a reduced sensitivity to the action of
insulin.
Hence, it is not surprising that the peak and average age at
presentation of type 2 diabetes mellitus in children coincides with
the usual age of mid-puberty approximately 13 years.
4. Obesity
Obesity is defined as excess adipose tissue in the body. It is
the hallmark of type 2 diabetes mellitus. Most of the children with
T2DM up to 85% are obese or overweight at diagnosis. Adipose
tissue expanding in the obese state synthesizes and secretes
metabolites & signalling proteins like leptin, adiponectin, and
tumor necrosis factor-alpha which alters the insulin secretion and
sensitivity and cause insulin resistance.
In a study conducted  by Weiss R, Dziura J et al (14) the
effect of obesity on glucose metabolism is evident early in
childhood and obese children are hyperinsulinemic and have
approximately 40% lower insulin stimulated glucose metabolism
compared with non obese children.
In a study conducted  by Taksali SE, Caprio S et al (15) there
is a inverse relationship between insulin sensitivity and abdominal
fat is stronger for visceral than for subcutaneous fat.
Haines L, Wan KC, Lynn R et al (12) did study in Argentina.
They studied 400 obese children who showed a prevalence rate of
1.6% for T2DM and 7% for IGT.
Definition of overweight and obesity:
According to WHO, (16)
Overweight is defined as > +1 Standard deviation (equivalent
to BMI 25 kg/square meters at 19 years). Obesity is defined as >+2
Standard deviation (equivalent to BMI 30kg/square meters).
The most commonly used and preferred indicator for obesity
is the body mass index (BMI). BMI has become the standard
practical measure of adiposity.
BMI =WEIGHT (Kg) / HEIGHT (m2)
Picture of BMI chart
5. Low Birth weight
Low birth weight is one of the risk factor for T2DM. The
following studies has clearly demonstrated the fact that low birth
weight babies born for mothers with high maternal BMI has higher
risk in future for developing T2DM.
Monica Gabbay, Paulo R. Cesarini et  al(8) study noted that
adults who were born with low birth weights with inadequate
intrauterine nutrition had a sevenfold risk of developing insulin
resistance, glucose intolerance and T2DM.
Erikkson et al (17) did a study on Effects of size at birth and
childhood growth on the insulin resistance syndrome in elderly
individuals.They studied 7086 men and women born in Helsinki,
Finland and they found that the development of Type II diabetes
mellitus is associated with low birth weight followed by accelerated
gain in height and weight during childhood and with high maternal
BMI. They concluded that the Insulin resistance and Type II
diabetes share common associations with retarded fetal growth and
accelerated growth during childhood
6. History of gestational diabetes in mother
ADA (3) defines Gestational diabetes as any degree of glucose
intolerance with onset or first recognition during pregnancy. The
definition applies regardless of whether insulin or only diet
modification is used for treatment or whether the condition persists
after pregnancy.
Anna V, van der Ploeg HP, Cheung NW et al (18) study
noted GDM mothers with a history of stillbirth or giving birth to an
infant with congenital abnormality and excess glucose in urine
during pregnancy has increased risk of obesity and type 2 diabetes
in offspring.
Monica Gabbay, Paulo R. Cesarini et al(8) study described
the increased risk of  T2DM  among the children of  GDM women.
An abnormal intrauterine environment is the key factor which is
responsible for the development of diabetes. Factors which
increases the insulin secretion is associated with the intrauterine
environment. Those factors have a direct effect on the fetus,
increasing insulin secretion leading to the development of insulin
resistance in the children.
CRITERIA FOR SCREENING FOR T2DM IN CHILDREN
AND ADOLESCENTS
Screening for diabetes is needed for at-risk asymptomatic
children to prevent Type 2 diabetes related morbidity and mortality.
Screening should commence at the age of 10 years at onset of
puberty and should be repeated every 2 years.
 ADA (3) suggests that children who are overweight (BMI,
85th percentile for age and sex) and who have any two of the
following risk factors should be tested for T2DM:
1. Family history of T2DM in first- or second-degree relative
2. Race/ethnicity (American Indian, African American,
Hispanic, Asian/Pacific Islander)
3. Signs of insulin resistance or conditions associated with
insulin resistance (acanthosis nigricans, hypertension,
dyslipidaemia, polycystic ovarian syndrome)
Recommended test by ADA is fasting plasma glucose. Hba1c
can    be used as alternative test.
HbA1c - SCREENING TEST FOR TYPE 2 DM:
HbA1c can be used as alternative test for screening T2DM.
The following studies described the use of HbA1c test in screening
diabetes.
Chirag Kapadia, Philip Zeitler et al (19)   conducted study in diabetic
patients and found HbA1c and FPG tests as equally effective screening
tools for the detection of Type 2 diabetes.
C. M. Bennett, M. Guo et al (20) study clearly described the
glycated haemoglobin (HbA1c) test as a screening tool for early
detection of Type 2 diabetes. They also noted HbA1c and FPG are
equally effective screening tools for the detection of Type 2
diabetes.HbA1c has higher specificity than fasting plasma glucose
(FPG) in detecting Diabetes. Hence HbA1c can be suggested as an
alternative screening test for Type 2 diabetes.
Pavithra Vijayakumar, Robert G. Nelson et al (21) study
described HbA1c as a useful predictor of diabetes risk in children
and can be used to identify prediabetes in children with type 2
diabetes risk factors with the same predictive value as FPG and
2hPG.
CUT OFF POINT FOR HbA1c:
In most of the diabetic studies(19,20,21) so far reviewed
recommends the HbA1c cut-off point of > 5.7 to 6.1% for detection
of Prediabetes and > 6.1% for the detection of Diabetes.
ADVANTAGES OF HbA1c TEST:
1. Compared with the OGTT, HbA1c measurement is quicker
and more convenient.
2. HbA1c can be measured at any time of the day regardless of
the duration of fasting or the content of the previous meal.
3. HbA1c levels represent a 2–3-month average of blood
glucose concentrations.
4. HbA1c, OGTT and FPG are equivalent as predictors of the
development of retinopathy and nephropathy
LIMITATIONS OF HbA1c TEST:
The accuracy of HbA1c is influenced by the presence of
haemoglobinopathy or renal failure, as well as laboratory error
and/or use of certain medications.
CRITERIA FOR DIAGNOSIS OF PRE DIABETES IN
CHILDREN AND ADOLESCENTS
According to ADA (3), Prediabetes is defined as
Impaired fasting glucose (IFG)
(Glucose level ? 100 mg/dl but <125 mg/dl)
or
Impaired glucose tolerance (IGT)
(2-hour postprandial ? 140-199 mg/dl)
or
        Glycated Hemoglobin level HbA1c >5.7 but < 6.1%
Prediabetes represents the earliest stages of impaired glucose
metabolism. Many studies have reported a high prevalence of
prediabetes in obese children and adolescents. Screening for
prediabetes should be considered for these high-risk children to
understand the early pathophysiologic changes underlying this
metabolic dysfunction and to halt the progression of prediabetes to
diabetes thereby preventing the diabetes related complications.
CRITERIA FOR DIAGNOSIS OF DIABETES IN CHILDREN
AND ADOLESCENT
American Diabetes Association (ADA) Criteria for DM (3):
1) Symptoms of diabetes (polyuria, polydipsia, and unexplained
weight loss) plus random  glucose level >200 mg/dl (11.1
mmol/l) in venous plasma or capillary whole-blood samples
or
2) Fasting glucose level >126 mg/dl (7.0 mmol/l) in venous
plasma or capillary whole-blood samples
or
3) 2 hour glucose level during oral glucose tolerance test
(OGTT) >200 mg/dl (11.1 mmol/l) in venous plasma or
capillary whole-blood sample.
or
4) HbA1c > 6.1%. The test should be performed in a laboratory
using a method that is NGSP certified and standardized to the
DCCT assay.
CLINICAL PRESENTATION OF T2DM IN CHILDREN AND
ADOLESCENTS (22)
Clinicians should be aware of the clinical presentation of
T2DM in children and adolescents. It includes the following
Age:  11yrs–17yrs
Gender: Female > male
Family history of T2DM
Overweight / Obesity
Acanthosis nigricans
Polycystic ovarian syndrome (PCOS)
Symptoms:
1. Mild form T2DM – Asymptomatic (or) mild polyuria and
polydipsia.
2. Severe form T2DM - Polyuria, polydipsia, and weight loss.
COMPLICATIONS OF DIABETES (23)
If diabetes is not treated properly at appropriate time,
complications will develop which endanger life and health. The
complications of diabetes are as follows,
1. Acute complications
2. Hypoglycemia
3. Multiorgan damage
Acute complications
Acute complications are due to the abnormally high blood
glucose level and can have a life-threatening impact.  Acute
complications are diabetic ketoacidosis (DKA) in type 1 and 2 and
hyperosmolar coma in type 2.
Hypoglycemia
Hypoglycemia is one of the complication of diabetes due to
abnormally low blood glucose that can also lead to seizures or loss
of consciousness. It is mainly due to skipping the meal or excessive
exercising more than usual, or due to the intake of anti-diabetic
drugs with high dosage.
Multiorgan damage
Over time diabetes can damage multiple organs which include
the heart, blood vessels, eyes, kidneys and nerves. It is the leading
cause of blindness and kidney disease. Diabetes patients are at
increased risk of developing the following diseases,
? Cardiovascular disease
? Stroke
? Diabetic Neuropathy in the feet which increases the chance of foot
ulcers, infection and the eventual need for limb amputation.
? Diabetic retinopathy is an important cause of blindness and occurs
due to the long-term accumulated damage to the small blood
vessels in the retina.
? Diabetic Nephropathy -   Renal failure.
Management of T2DM in Children and Adolescents (4)
Goal of Management of T2DM in Children And Adolescents
The ideal goal of treatment is normalization of blood glucose
values and HbA1c. Successful control of the associated co
morbidities is also important. The ultimate goal of treatment is to
decrease the risk of acute and chronic complications associated
with diabetes mellitus. There are three main steps in the
management of T2DM.
1. Weight management
2. Pharmacological Management of T2DM
3. Management of complications of T2DM
1. Weight Management in Children and Adolescents
Weight control is the initial management of obese children
and adolescents with T2DM consists of lifestyle and behaviour
modifications like decreasing high-caloric high-fat food choice
while increasing the physical activity. Referral to a dietician for
nutritional management of children with diabetes mellitus is
necessary. Encouraging healthy eating habits by the entire family is
important.
2. Pharmacological management of T2DM in Children and
Adolescents
Indication for Pharmacological treatment:
Pharmacological therapy is indicated if treatment goal
(HbA1c < 7%) with diet and exercise is not met.
Drug of choice:
Many drugs are available for treatment of type 2 diabetes but
only metformin and insulin are drug of choice for use for under 18-
year-old.
Oral anti diabetic drug:
Most of the doctors use oral agents for children with type 2
diabetes mellitus. Advantages of oral agents include potentially
greater compliance and convenience for the patient. The oral anti
diabetic drug of choice is Metformin.
Insulin treatment:
If monotherapy with metformin for a period of 3-6 months is
not successful Insulin treatment should be started.
Metformin treatment in T2DM in children and adolescents:
Metformin, a biguanide, is the most appropriate drug for
pharmacological treatment in children with type 2 diabetes
mellitus.
Action of Metformin:
Metformin decreases hepatic glucose output and enhances
primarily hepatic and also muscle insulin sensitivity without a
direct effect on ?-cell function.
Dose of metformin: up to 2 g in split doses
Advantages of metformin:
Metformin has the advantage of weight reduction, decrease in
lipids without the risk of hypoglycaemia.
Side effect of metformin:
The most common side effects of metformin are
gastrointestinal disturbances. The other side effect is lactic
acidosis. Hence metformin is contraindicated in patients with
impaired renal function
Insulin treatment:
If monotherapy with metformin for a period of 3-6 months is
not successful insulin treatment should be started. There is no
specific contraindication to insulin in children. Insulin regimes can
be adjusted according to the level of blood glucose (bedtime insulin
alone, twice-a-day insulin or multidose insulin regimes).
3. Management of complications T2DM in children and
adolescents
1. Dilated eye examinations should be performed to detect
retinopathy.
2. Screening for microalbuminuria should be performed yearly
to detect nephropathy. Angiotensin converting enzyme (ACE)
inhibitors are the agents of choice in children with
microalbuminuria.
3. Control of hypertension in diabetes mellitus is necessary. If
normotension is not achieved by ACE inhibitors, combination
therapy with a-blockers, calcium antagonists or low-dose
diuretics may be needed.
4. Testing for and treating lipid abnormalities are necessary to
avoid macro vascular diseases.
PREVENTION OF T2DM IN CHILDREN AND
ADOLESCENTS  (24)
Prevention of type 2 diabetes mellitus means prevention of
obesity in childhood. Prevention should start very early in life,
perhaps even before birth.
To prevent the development of type 2 diabetes mellitus and
its life-shortening complications early detection of impaired
glucose regulation may represent an appropriate strategy to prevent
type 2 diabetes mellitus, as subjects with impaired glucose
tolerance are at increased risk of  developing this disease.
Adoption of a healthy lifestyle characterized by healthy
eating, regular physical activity and subsequent modest weight loss
can prevent the progression of impaired glucose tolerance to
clinical diabetes mellitus.
Prevention of diabetes can be done at two levels.
1. Primary Prevention
2. Secondary Prevention
Prevention of Childhood obesity and T2DM:
Population and community approach for prevention of obesity
in childhood and hence type 2 diabetes mellitus in childhood and
adolescence seems to be the most promising and reasonable
treatment strategy available at present. Family based, behavioural
treatment for obesity is also effective in preventing type 2 diabetes
mellitus and is also extremely cost-effective. Good nutrition and
modest exercise for pregnant women as well as monitoring of
intrauterine growth of the foetus are mandatory. After birth, rapid
weight gain should be avoided and the principles of good nutrition
and physical activity be taught at all ages. Breast-feeding should be
strongly recommended. Children’s food choice can be influenced
by early intervention and guidance. In fact, teacher training,
modification of school meals and physical education are effective
in reducing risk factors for obesity.
Primary prevention:
The main modes in primary prevention is lifestyle
modification which includes
A) Measures to prevent obesity by encouraging Physical activity,
exercise and healthy food habits.
B) Promotion of breast feeding.
Secondary prevention:
The main step in secondary prevention is  to delay or prevent
the development of complications of diabetes. Following measures
can be taken
1. Early screening and diagnosis of  DM
2.  Good control of blood sugar.
3. Good Control of blood pressure.
4. Early screening for long term morbidities and mortalities.
5. Medical education for diabetes.
6.  Emotional and social support.
REVIEW OF LITERATURE
The purpose of our study is to screen the Obese children with
positive family history of diabetes  and those children with signs of
insulin resistance or conditions associated with insulin resistance
(acanthosis nigricans, hypertension, dyslipidemia, polycystic
ovarian syndrome) should be screened for T2DM using HbA1c test
as screening tool. ADA  (3) recommends using HbA1c test  as  one of
the screening test. General screening for type 2 diabetes mellitus in
youth is unlikely to be cost effective. Therefore a targeted
screening seems to be necessary.
Mazza CS, Ozuna B, Krochik AG et al (25) did a study in
Germany. They included 500 obese children and adolescents who
showed a prevalence rate of 1.5% for T2DM and 2.1% for IGT.
Excess body fat is the strongest risk factor for type 2 diabetes.
Overweight and obesity, together with physical inactivity, are
estimated to cause a large proportion of the global diabetes burden.
From the above study it is clear that obesity is the main factor in
developing T2DM in children and adolescents. Hence in ours study
we did a targeted screening for T2DM in obese children
NEED OF SCREENIG FOR T2DM IN CHILDREN:
The following studies highlighted the importance of early
screening for T2DM,
Hillier TA , Pedula KL et al(23) study clearly described type
2 diabetes mellitus developing at a younger age is associated with a
much higher risk of long-term cardiovascular disease than those
who develop type 2 diabetes mellitus in middle age group. Hence
early targeted screening for T2DM is needed in high risk children.
Eppens MC, Craig ME et al (26) study mentioned the
important fact that Screening of young people with type 2 diabetes
mellitus is necessary since they are at a much higher risk of
developing early diabetes mellitus associated complications than
those with type 1 diabetes mellitus. They also noted this higher
level of risk is related to occurrence of hypertension and
dyslipidemia associated with childhood obesity. Hence early
screening of obese children for T2DM is needed and also measures
to take modification of life style to prevent childhood obesity must
be emphasized.
Copeland KC, Zeitler P et al (27)study described
cardiovascular risk factors are more frequent in adolescents
suffering from type 2 diabetes mellitus compared to type 1 diabetes
mellitus. Hence to reduce the T2DM related complication we need
early screening for at risk children and adolescents.
The DECODE study group (28) described the Development of
type 2 diabetes mellitus and its life-shortening sequelae can be
prevented by early detection of impaired glucose regulation.
Children with impaired glucose tolerance are at increased risk of
developing diabetes in future. Hence early screening represents an
appropriate strategy to prevent type 2 diabetes mellitus.
Helena W. Rodbard et al study(29) discussed the dramatic rise in
the incidence and prevalence of type 2 diabetes mellitus in the paediatric
and adolescent populations and its association with the ongoing epidemic
of overweight, obesity, insulin resistance, and metabolic syndrome seen
in these age groups. 50% of patients with diabetes in the paediatric age <
18 years have type 2diabetes. Hence screening of high-risk children for
diabetes and prediabetes is important for early intervention in terms of
lifestyle changes, hopefully leading to avoidance or delay of the
development of diabetes.
HbA1c TEST AS SCREENING TEST FOR DIAGNOSIS OF
DIABETES
The following studies support the use of HbA1c test as
screening test for diagnosis of diabetes.
In a study conducted by Tapp RJ, Tikellis G, et al (30) found a
stronger correlation between HbA1c and retinopathy than between
fasting glucose levels and retinopathy.
Stratton IM, Adler AI, Neil HA et al(31) conducted a
controlled clinical trial study in type 2  diabetes and found the
strong correlation between HbA1c levels and macro vascular and
micro vascular complications of type 2 diabetes.
Weykamp C, John WG, Mosca A et al (32) did a 6year study
on  The IFCC reference measurement system for HbA1c and
reported that preanalytic errors owing to sample handling is more in
FPG measurement than HbA1c assay. HbA1c values are relatively
stable after collection, and the recent introduction of a new
reference method to calibrate all HBA1c assay instruments has
further improved A1c assay standardization.
Miller  WG,  Myers  GL,  Ashwood  ER et  al  study  (33) analysed
the performance of a variety of clinical laboratory instruments and
methods that measure glucose and they found 41% of instruments
have a significant bias from the reference method leading to
misclassification of 12% of patients. Hence the measurement of
glucose alone is less accurate and precise. Storage of blood samples
at room temperature for as little as 1 to 4 h before analysis
decreases the glucose levels by 3–10 mg/dl. Hence Hba1c can be
used along with FPG to detect diabetes.
Ollerton RL, Playle R, et al study (34) showed the variability
of HbA1c values is considerably less than that of FPG levels, with
day-to-day and within-person variance of  2% for A1C but 12–15%
for FPG
International expert committee (35) was convened in 2008 to
consider the current and future means of diagnosing diabetes and
the Committee made its report on the role of the HbA1c assay in
the diagnosis of diabetes.
In 1997 expert committee report was against the use of
HbA1c values for diagnosis of diabetes because of the lack of assay
standardization.
 After the National Glycohemoglobin Standardization
Program had succeeded in standardizing HbA1c assays, the current
Expert Committee examined the laboratory measurements of
glucose and A1C assay and they reported that with advances in
instrumentation and standardization, the accuracy and precision of
A1C assays match those of glucose assays. Committee has
concluded HbA1c as a laboratory measure of chronic glycemia and
a more stable biological marker than FPG which is known to
fluctuate within and between days.
All of these studies  (30, 31, 32, 33, 34, 35) suggest that HbA1c as a
reliable measure of chronic glycemic levels and also related more
intimately to the risk of complications. HbA1c may serve as a
better biochemical marker of diabetes and should be considered a
diagnostic tool. The convenience for the patient and ease of sample
collection for A1c testing (which can be obtained at any time,
requires no patient preparation, and is relatively stable at room
temperature) compared with that of FPG testing (which requires a
timed sample after at least an 8-h fast and which is unstable at room
temperature) support using the A1c assay to diagnose diabetes.
The following studies are reviewed for our study references :
Thomas reinter, et al (4) did “A Study of Type 2 Diabetes
Mellitus in Children and Adolescents”. They did screening in high
risk children and adolescents with family history of with T2DM,
obese children and those with clinical features of insulin resistance
such as hypertension, dyslipidemia, polycystic ovarian syndrome or
acanthosis nigricans. For diagnosis of DM they used the following
criteria,
a) Symptoms like polydipsia, polyuria and unexplained weight
loss
b) Casual glucose concentration ?200mg/dl in venous plasma,
fating glucose ?126mg/dl in venous plasma or two hour
glucose during OGTT?200mg/dl in venous plasma and
HbA1c ? 6.5%.
In this study they demonstrated type 2 diabetes mellitus in
1% of screened obese children in Germany and 4% of screened
obese adolescents with high risk ethnic groups in the United States.
They used HbA1c as one of the screening tool in diagnosis of DM
since HbA1c test has been included in the ADA (3) recommendation
for the diagnosis of diabetes. They also suggested HbA1c can be
used as screening tool for the diagnosis of T2DM in children and
adolescents after the standardisation of HbA1c test.
Jinan B.saddiine,  et  al (36) did “A Study of Distribution of
HbA1c Levels for Children and Young Adults”  in  the  U.S.
Concentration of HbA1c is an indicator of average blood glucose
concentration over the preceding 2-3 months. A total of 7,974
children, adolescents and young adults aged 5-24 years who were
not treated for diabetes had their HbA1c levels measured. The mean
age was 15 years, 49% were men and 11% were overweight. The
overall sex-related differences in HbA1c means levels were
significant but very small. In this study, statistically higher mean
HbA1C level were noted in the 10-14 year old age group,
overweight participants, those with lower levels of education i.e.
those with low Socioeconomic status  ,those with a positive
parental history of diabetes and those with serum
glucose?126mg/dl. They described these differences in HbA1c may
reflect higher average glycemia over the preceding 2–3 months or it
may reflect some level of relative insulin resistance. Indeed, an
elevated HbA1c level has been associated with excess mortality
risk in the general population. They also described the higher
HbA1c level in the age group of 10-14 years may be due transient
increase in insulin resistance at the onset of puberty and the return
to near pre pubertal insulin sensitivity level by the end of puberty.
K .A. MATYKA, et al (37) did an “A STUDY OF TYPE 2
DIABTES IN CHILDHOOD: EPIDEMIOLOGICAL AND CLINICAL
ASPECTS”, and they discussed about the obesity epidemic and risk
of type 2 diabetes in childhood. In this study they discussed the risk
factors for T2DM. Regarding ethnicity the Indo-Asians are at high
risk for developing diabetes. In this study majority of children with
T2DM had family history of diabetes. According to their study the
recent increase in the prevalence of childhood T2DM was linked to
the increase in childhood obesity.
C. M. Bennett,  M. Guo and S.  C.  Dharmage et  al (19) did  a
study to assess the validity of glycated haemoglobin A1C in early
detection of Type 2 diabetes. They had done a Systematic review of
primary cross-sectional studies (about 63 studies) for the accuracy
of HbA1c for the detection of Type 2 diabetes using the oral
glucose tolerance test as the reference standard and fasting plasma
glucose as a comparison. They have demonstrated that HbA1c has
slightly lower sensitivity than fasting plasma glucose (FPG) in
detecting diabetes, but has slightly higher specificity HbA1c and
better predict both micro- and macro vascular complications. They
concluded HbA1c and FPG as equally effective screening tools for
the detection of Type 2 diabetes.
Pavithra Vijayakumar, Robert G. Nelson et al (20) did a
study about HbA1c and the Prediction of Type 2 Diabetes in
Children and Adults. They included 2,095 American Indian
children, adolescents, and adults children without diabetes aged 10–
19 years and followed them every 2years.Children and adults
underwent comprehensive clinical examinations, which included
detailed medical histories, anthropometric measurements, and
biochemical tests. They measured FPG, 2hPG and HbA1c in all
these subjects. HbA1c was measured by high performance liquid
chromatography.  Participants were classified into prediabetes (5.7–
6.4%), intermediate (5.4–5.6%), or lower (<5.3%) baseline HbA1c
categories. During long-term follow-up of children and adolescents
who did not initially have diabetes, the incidence rate of subsequent
diabetes was fourfold (in boys) as high and more than sevenfold (in
girls) as high in those with HbA1c 5.7% as in those with HbA1c
5.3% category.  Their analysis revealed no significant differences
between HbA1c, FPG, and 2hPG in sensitivity and specificity for
identifying children and adolescents who later developed diabetes.
Hence they suggested HbA1c as a useful predictor of diabetes risk
in children and can be used to identify prediabetes in children with
other type 2 diabetes risk factors with the same predictive value as
FPG and 2hPG.
Stefan Ehehalt, Antje Körner et al (38) did a study “Diabetes
screening in overweight and obese children and adolescents:
choosing the right test”. Type 2diabetes can occur without any
symptoms. They performed an observational analysis of 4848 (2668
female) overweight and obese children aged 7 to 17 years without
previously known diabetes. They used HbA1c (?6.5%) and OGTT
2-h glucose levels ?200 mg/dl as diagnostic criteria for diagnosis of
diabetes. About 2.4% (n = 115, 55 female) were classified as
having diabetes. Out of the 115 cases fulfilling the OGTT and/or
HbA1c criteria for diabetes, diabetes was confirmed in 43.5%.
Within this group, 68.7% had HbA1c levels ?48 mmol/mol (?6.5%)
and 46.1%. had FPG ?126 mg/dl (?7.0 mmol/l) and/or 2-h glucose
levels ?200 mg/dl (?11.1 mmol/l). In their study analysis they
found, an optimal threshold to diagnose diabetes for FPG as
98 mg/dl (5.4 mmol/l) (sensitivity 70%, specificity 88%) and for
HbA1c, the best cut-off value was 42 mmol/mol (6.0%) (Sensitivity
94%, Specificity 93%). Hence they concluded HbA1c as more
reliable test than OGTT for diabetes screening in overweight and
obese children and adolescents. They also suggested optimal
HbA1c threshold for identifying patients with diabetes as 6.0%.
STUDY JUSTIFICATION
1. India has the largest number diabetes mellitus patient in the
world. Many clinical oriented diabetic studies shows that the
prevalence and incidence of type 2 DM in children and
adolescent is increasing among indoasians Indian children
belongs to a high risk ethnic group, so all overweight/obese
children >10 years  with any  risk factors  for T2DM should
be screened for Type 2DM.
2. At risk children for T2DM but asymptomatic for long period
may remain undiagnosed. Screening is needed in such
situation.
3. Type 2 diabetes related morbidity and mortality can be
decreased by early screening and intense treatment in the
early stage. Hence screening  for T2DM is needed to avoid
complications like retinopathy, nephropathy.
4. T2DM can be prevented, if  children are treated in the pre-
diabetes stage itself.
Hence screening  and  early  identification  of children   in the
age  group of 10-18 years  with  risk  factors for Type 2DM is
essential  for  preventing  long  term organ  dysfunction.
AIM OF THE STUDY
The main aim of our study is to screen the children of Type 2
Diabetic mellitus Parents for early detection of diabetes by HBA1C
test to prevent long term consequences of diabetes mellitus.
SUBJECTS AND METHODS
METHODOLOGY
STUDY DESIGN:
Cross sectional study
STUDY POPULATION:
Adolescent children aged 10-18 Years of Parents having
Type2 Diabetes Mellitus
PLACE OF STUDY:
Govt. Royapettah Hospital, Chennai.
SOURCE OF DATA:
 Diabetic OP and Paediatric OP at Govt. Royapettah Hospital
Chennai.
STUDY PERIOD:
March 2017 to August 2017- 6 months
INCLUSION CRITERIA:
All adolescent children aged between  10-18  years   with
one or both  parents  having  Type  2 Diabetes  Mellitus.
EXCLUSION CRITERIA:
1. All children and adolescents with known Type 1 Diabetes
Mellitus (Insulin Dependent Diabetes Mellitus).
2. All children and adolescents suffering from Chronic
Pancreatic Disorders.
3. All children and adolescents suffering from other Endocrine
Disorders
ETHICS:
Ethical committee clearance was obtained from our
Institutional Review Board.
SAMPLE SIZE: 140
SAMPLE SIZE DETERMINATION: Sample size
Determination is based on the following study
Study: Long term consequences for offspring of Paternal
Diabetes and Metabolic Syndrome
Authored by: Benigno Linares Segovia et al.
Published in: Experimental Diabetes Research Volume 2012
Journal.
Calculation: In the above study following calculations were
followed.
The confidence level is estimated at 95% with a z value of
1.96.
The confidence interval or margin of error is estimated at +/-8
Assuming p% = 37.00 and q% = 63.00
n = p% x q% x [z/e%] ^2
n = 37.00 x 67.00 x [1.96/8] ^2
n = 139.92 (rounded to 140)
Therefore 140 is the minimum sample size required for the
study assuming 80% as the power of study.
METHOD OF COLLECTION OF THE CLINICAL DATA
Type 2 Diabetes mellitus patients who came to Diabetic OP at
Govt Royapettah Hospital have been advised to bring their
adolescent children aged between 10-18 years for the diabetic
screening.
All children aged between 10-18 years who were brought by
the parents were enrolled in my study. Detailed  history  regarding
the  onset, duration and  mode  of treatment  of  type 2 diabetes
mellitus in  the  parents  were  noted.
 Complete examination including anthropometry & signs of
insulin resistance like acanthosis nigricans, PCOS in female child
[by USG], and Blood pressure measurement has been recorded for
all those children.
Blood has been collected under aseptic sterile technique in
fasting state and sent to the laboratory for measurement of HbA1c
level.
Children with HbA1c level more than >5.7 % were further
evaluated by FPG and OGTT for further management.
CLINICAL QUESTIONNAIRE
PARENT’S DETAILS:
The questions were asked about parent’s education level and
employment status, consanguinity between the parents as well as
information regarding the child’s health condition.
CHILDREN DETAILS:
 Information was collected regarding the children’s clinical
history.
Family history: Documented evidence of diabetes mellitus in
parents, sibling, paternal and maternal grandparents, maternal and
paternal aunty (or) uncle.
Physical activity: Physical activity score were recorded
based on different levels of physical leisure activity. Physical
activity score was based on the validated questionnaire for physical
exercise taken from the National Diabetes Register (NDR),
Sweden’s national quality registers operated by the Swedish
Society for Diabetology.
PHYSICAL ACTIVITY SCORE:
No activity, activity (1 time/ week)
Regular activity (1–2 times/week),
Regular activity (3–5times/week)
Regular daily activity
SYMPTOMS OF HYPERGLYCAEMIA:
The following symptoms of hyperglycaemia were enquired in
all children included in the study,
? Excessive Thirst And Drinking
? Frequent Urination
? Recent Weight Loss
? Fatigue
? Recurrent Thrush Or Skin Infections
TOOLS USED IN THE STUDY:
1. Digital Weighing Scale for Weight
2. Stadiometer for Height
3. Sterile Tube for collection of Blood for HBA1C
MEASUREMENTS DONE IN THE STUDY:
1. Anthropometric Measurements
Measurement of Weight
Measurement of Height
Calculation of BMI
2. Acanthosis nigricans
3. Blood pressure measurement
4. USG study for Female children
5. Blood collection for HBA1C Measurement
1. ANTHROPOMETRIC MEASUREMENTS
These measurements were carried out in all my study subjects
for calculating BMI to detect overweight and obesity in children
which is one of the risk factor for T2DM.
WEIGHT MEASUREMENT PROCEDURE:
Weight was taken using a Digital Weighing Scale to the
nearest 0.1kg, which was calibrated every day with a standard
weight. The weight was taken after removing the footwear but no
adjustments were made for the weight of the dress worn during the
examination.
HEIGHT MEASUREMENT PROCEDURE:
Height was recorded to the nearest 0.1cm using an in-built
stadiometer. The height was taken after removing the footwear. The
height was measured with child standing in erect posture with
heels, buttocks and back in close contact with the stadiometer. The
head was positioned with child looking forward so that the
Frankfurt plane (the line joining floor of external auditory meatus
to  the  lower  margin  of orbit) and the biauricular plane were
horizontal.
CALCULATION OF BMI:
Quetlet Index was used to calculate BMI. The children were
classified into overweight (or) obesity using WHO Z-scores
reference.
BMI = WEIGHT IN kg / HEIGHT IN m2
1. Overweight (BMI 25 to 30)
BMI > +1SD to < +2SD for age and sex.
2. Obesity (BMI >30)
BMI > +2SD to +3SD for age and sex.
2. ACANTHOSIS NIGRICANS
It is characterized by dark, thick, velvety, pigmented skin in
the neck and axilla. The most commonly used site to find
acanthosis nigricans in our study was neck area since it is found
that this site was commonly involved in acanthosis nigricans in 93
to 99% of the cases as evident from the previous studies. It is also
easy to expose the neck area in practical settings and it is more
comfortable for the subjects to expose the neck area than other
areas.
3. BLOOD PRESSURE MEASUREMENT (BP)
BP was measured using Mercurial type Sphygmomanometer
with appropriate cuff size. Prior to taking BP readings all children
were instructed to rest for at least 10 minutes in an air-conditioned
environment. Measurements were taken two times on the right arm
with short intervals between readings, and the average of BP
readings was calculated and used for analysis.
4. USG STUDY FOR FEMALE CHILDREN
Ultra sonogram of abdomen and pelvis was done for all
female children and we used ROTTERDAM CRITERIA for
detecting PCOS in female children. When 2/3 of the following
criteria are met, female children were categorised as having PCOS.
1. Oligo or anovulation
2. Polycystic ovaries on ultrasonography (12 or more follicles in
a single ovary or ovarian volume of >10ml in 1 ovary)
3. Clinical and/or biochemical hyperandrogenism.
5. HbA1c MEASUREMENT
Fasting venous blood sample( after a eight hours fasting) was
drawn for all children included in the study and taken to laboratory
immediately under full aseptic and cold chain precautions for
HbA1c measurement.HbA1C test was done using the standardised
High performance liquid chromatography method.
HbA1c measurement was used as the screening test for the
diagnosis of pre-diabetes and diabetes in my study as it was
convenient, easier and faster to perform. The oral glucose tolerance
test although considered the ‘gold standard,’ was time consuming
than the HbA1c test and also HbA1c has higher specificity
compared to fasting blood sugar.
Cut off criteria used in my study is as follows
                  HbA1c < 5.7 classified as normal.
HbA1c > 5.7 to 5.9 classified as prediabetes.
HbA1c > 6.1 classified as diabetic
OBSERVATION AND ANALYSIS
140 children and adolescents were enrolled in the study on
the basis of inclusion and exclusion criteria. The data entry was
done in Microsoft Excel sheet.
STATISTICAL METHODS: Diabetic status and HbA1c are
primary outcome variable. Age, Gender, Family history of Diabetic,
Anthropometric parameters and if presence Acanthosis Nigricans
was considered as explanatory variable.
DESCRIPTIVE ANALYSIS: Descriptive analysis was
carried out by mean and standard deviation for quantitative
variables, frequency and proportion for categorical variables. Data
was also represented using appropriate diagrams like bar diagram,
pie diagram and box plots.
INFERENTIAL STATISTICS:
The association between explanatory variables and
categorical outcomes was assessed by cross tabulation and
comparison of percentages. Chi square test was used to test
statistical significance.
 P value < 0.05 was considered statistically significant. IBM
SPSS version 22 was used for statistical analysis.
Table 1: Descriptive analysis for Age in study population
(N=140)
Parameter Mean±STD Median Min Max
95% C.I. for EXP(B)
Lower Upper
Age 14.5± 2.87 15.00 10.00 9.00 14.03 14.99
The mean of age was 14.51 years with a standard deviation of
2.87. The youngest person was 10years old and the oldest person
was 19-years-old. (Table1)
Table 2: Descriptive analysis of Age group in study population
(N=140)
Age group Frequency Percentages
10-12 years 45 32.14%
13-15years 31 22.14%
16-19years 64 45.71%
Among the study population, the age group 10-12 years was
32.14%, 13-15 and 16 -19 years was 22.14% and 45.71%
respectively. (Table 2 & figure 1, 2)
Figure 1: Pie chart of Age group distribution in study
population (N=140)
Figure 2: Bar chart of Age groups in study population (N=140)
Table 3: Descriptive analysis of Gender in study population
(N=140)
Gender Frequency Percentage
Male 86 61.43%
Female 54 38.57%
Among the study population, the proportion of boys were
61.43% and 38.57% were girls. (Table 3 & figure 3)
Figure 3: Bar chart of Gender distribution in study population
(N=140)
Table 4: Descriptive analysis of Diabetic H/o Mother in study
population (N=140)
Diabetic H/o Mother Frequency Percentage
Yes 71 50.71%
No 69 49.29%
Among the study population, the   Family history of diabetes
in Mother was present in 50.71% of subjects. (Table 4 & figure 4)
Figure 4: Bar chart of Diabetic H/o Mother in study population
(N=140)
Table 5: Descriptive analysis of Diabetic H/o Father in study
population (N=140)
Diabetic H/o Father Frequency Percentage
Yes 83 59.29%
No 57 40.71%
Among the study population, the   Family history of diabetes
in Father was present in 59.29% of people. (Table 5 & figure 5)
Figure 5: Bar chart of Diabetic H/o Father in study population
(N=140)
Table 6: Descriptive analysis for Height in study population
(N= 140)
Parameter Mean±STD Median Min Max
95% C.I .for
EXP(B)
Lower Upper
Height 153.53±9.94 156.00 123.00 172.00 151.87 155.19
The Mean height of study population was 153.53± 9.94 with
minimum 123 cm and Maximum 172 cm (95 C.I 151.87 to
155.19).(Table 6).
Table 7: Descriptive analysis for Weight in study population
(N= 140)
Parameter Mean±STD
Medi
an Min Max
95% C.I. for
EXP(B)
Lower Upper
Weight 47.91±9.75 49.00 22.00 70.00 46.28 49.54
The Mean weight of study population was 47.91± 9.75 with
minimum 22 kg and Maximum 70 kg (95 C.I 46.28 to 49.54).
(Table 7)
Table 8: Descriptive analysis for BMI in study population
(N=140)
Parameter Mean±STD Median Min   Max
95% C.I. for
EXP(B)
Lower Upper
BMI 20.32±3.26 19.67 14.60 28.80 19.77 20.86
The Mean BMI of study population was 20.32± 3.26 with
minimum 14.60 and Maximum 28.80 (95 C.I 19.77 to 20.86).
(Table 8)
Table 9: Descriptive analysis of BMI category in study
population (N=140)
BMI category Frequency Percentages
Under weight 40 28.57%
Normal 82 58.57%
Over weight 18 12.86%
Among the study population, the BMI category of
Underweight was 40(28.57%), normal and overweight was
82(58.57%) and 18(12.86%) respectively. (table9 & figure 6, 7)
Figure 6: Bar chart of BMI category distribution in study
population (N=140)
Figure 7: Pie chart of BMI category distribution in study
population (N=140)
Table 10: Descriptive analysis for BP Systolic in study
population (N=140)
Parameter Mean±STD Median Min Max
95% C.I. for
EXP(B)
Lower Upper
Systolic BP 101.64 ±7.38 100.00 90.00 120.00 100.41 102.88
The Mean Systolic BP of study population was 101.64± 7.38
with minimum 90 and Maximum 120 (95 C.I 100.41 to 101.88).
(Table 10)
Table 11: Descriptive analysis for BP Diastolic in study
population (N= 140)
Parameter Mean±STD Median Min Max
95% C.I. for
EXP(B)
Lower Upper
Diastolic
BP
70.21 ±
2.54 70.00 60.00 80.00 69.79 70.64
The Mean Diastolic BP of study population was 70.21± 2.54
with minimum 60 and Maximum80 (95 C.I 69.79 to 70.64). (Table
11)
Table 12: Descriptive analysis of Acanthosis Nigricans in study
population (N=140)
Acanthosis Nigricans Frequency Percentage
Yes 27 19.29%
No 113 80.71%
Among the study population 19.29% people had Acanthosis
Nigricans. (Table 12 & figure 8)
Figure 8: Bar chart of Acanthosis Nigerians distribution in
study population (N=140)
Table 13: Descriptive analysis of USG (female) in study
population (N=54)
USG (female) Frequency Percentages
Normal study 52 96.30%
Prominent
ovaries/PCOD 2 3.70%
Among the study population, Ultra sound study (female) was
normal in 52(96.30%) of the female subjects. PCOD was present in
2 (3.70%) of female subjects (table 13 & figure 9)
Figure 9: Pie chart of USG (female) distribution in study
population (N=54)
Table 14: Descriptive analysis for HbA1c in study population
(N=140)
Parameter Mean±STD Median Min Max
95% C.I. for
EXP(B)
Lower Upper
HbA1c 4.9 ±0.31 4.90 4.10 5.80 4.85 4.96
The Mean HbA1c of study population was 4.9± 0.31 with
minimum 4.10 and Maximum 5.80 (95 C.I 4.85 to 4.96). (table14)
Table 15: Descriptive analysis of HbA1c category in study
population (N=140)
HbA1c category Frequency Percentage
up to 5.6 (Normal) 136 97.14%
5.7to 5.9 (Prediabetes) 4 2.86%
Among the study population, the HbA1c category of up to 5.6
and was present in 97.14% and the HbA1c category of 5.7 to 5.9
was 2.86% respectively. (Table 15& figure 10)
Figure 10: Bar chart of HbA1c category in study population
(N=140)
Part-II: Factors associated with High HbA1c (Prediabetes and
diabetes) level
Table 16: Association of HbA1c category with Age group of
study population (N=140)
Age
group
HbA1c category
Chi
square
P
valueupto5.6(N=136)
(Normal)
5.7to 5.9(N=4)
(Prediabetes)
10-12
years 43 (31.62%) 2 (50%)
.810a 0.667
13-
15years 30 (22.06%) 1 (25%)
16-
19years 63 (46.32%) 1 (25%)
Among the HbA1c up to 5.6 normal category (normal HBA1C
level) 43 (31.62%) were aged between 10-12 years, 30 (22.06%)
were aged between 13-15 years and 63 (46.32%) were aged
between 16-19 years was respectively. Among subjects with HbA1c
5.7 to 5.9 category (Pre diabetic), the number of  subjects in Age
group 10-12, 13-15 and 16-19 years were 2 (50%), 1 (25%) and 1
(25%) respectively. The differences in HBA1C level and specific
age group were statistically not significant (P value 0.667). (table16
& figure 11)
Figure 11: Bar chart of comparing Age group of the two study
groups (N=140)
Table 17: Association of HbA1c category with Gender of study
population (N=140)
Gender
HbA1c category Chi
square
P-
valueUp to 5.6 (N=136)
(Normal)
5.7to5.9 (N=4)
(Prediabetes)
Male 85 (98.84%) 1 (1.16%)
2.306a 0.129
Female 51 (94.44%) 3 (5.56%)
Among the HbA1c   up to 5.6 category 85(98.84%) were
Male and51 (94.44%) were Female. The number of Male and
Female was 1 (1.16%) and3 (5.56%) in HbA1c 5.7 to 5.9 category.
The differences in gender proportion between the two groups was
statistically not significant (P value 0.129) (table 17 & figure 12)
Figure 12: Bar chart of comparing gender composition of the
two study groups (N=140)
Table 18: Association of HbA1c category with BMI category of
study population (N=140)
BMI category
HbA1c category
up to 5.6(N=136)
(Normal)
5.7to 5.9(N=4)
(Prediabetes)
Under weight 40 (29.41%) 0 (0%)
Normal 79 (58.09%) 3 (75%)
Over weight 17 (12.5%) 1 (25%)
No statistical test was applied considering “0” subjects in one
of the BMI category.
Among the HbA1c   up to 5.6 normal category 40 (29.41%)
were under weight, 79 (58.09%) were Normal Weight and 17
(12.5%) were Overweight children. The number of Normal and
Overweight children in HbA1c 5.7 to 5.9 prediabetes category were
3 (75%) and 1 (25%). (Table 18& figure 13)
Figure 13: Bar chart of comparing BMI category of the two
study groups (N=140)
Table 19: Association of HbA1c category with USG (female) of
study population (N=54)
USG (female)
HbA1c category Chi
square
P-
valueup to 5.6 5.7 to 5.9
Normal study 50(98.04%) 2 (66.67%)
7.819a 0.005
Prominent
ovaries/PCOD 1 (1.96%) 1 (33.33%)
         Among the HbA1c up to 5.6 category 50 females (98.04%)
were     Normal  and 1female child (1.96%) had PCOD. Among the
HbA1c 5.7 to 5.9 category 2 females (66.67%) had Normal USG
and 1 female  (33.33%) had PCOD. The differences in USG
between the two groups were statistically significant (P value
0.005).
Bar chart of comparing USG (female) of the two study groups
(N=54)
DISCUSSION
Children of T2DM parents were chosen for conducting the
study because it is proven in many clinical trial studies that  type 2
diabetes  run in families. Hence we instructed the diabetic patients
(father/mother) who all came to the Diabetic op to bring their
adolescent children aged 10-19 years for diabetic screening using
various clinical and biochemical parameters.
140 children were brought by the parents and were included
in our study. We divided the children into three groups to know any
age specific variation in HbA1c level. Age groups were 10-12
years, 13-15years and 16-19years. Among the study population,
children in the age group of 10-12 years were 45 in number
(32.14%), children in the age group of 13-15years were 31 in
number (22.14% ) and 16 -19 years age group were 64 in number (
45.71% ). Majority of the subjects in our study belonged to 16-19
years (45.71%) i.e. adolescent age.
Among the study population, boys were 86 in number
(61.43%) and girls were 54 in number (38.57%). Majority of the
children in our study were male children (61.43%).
All the children have family history of diabetes either in
father or mother or both. Among the study population, the family
history of diabetes in Mother was present in 59 children, family
history of diabetes in father was present in 71children and family
history of diabetes in both mother and father was present in 12
children.
Height and weight of all the children included in the study
were measured and Body mass index was calculated. Based on the
BMI children were divided into underweight, overweight or obese.
Among the study population, 40 children (28.57%) belonged to the
BMI category of Underweight and 82 children (58.57%) belonged
to the BMI category of Normal weight and 18 children belonged to
the BMI category of overweight (12.86%).
Systolic and Diastolic BP was measured in all children. All
the 140 children have normal BP.
All the children included in the study were examined for
Acanthosis Nigricans. Among the study population 27 children
(19.29%) were noted to have Acanthosis Nigricans.
All the 54 female children underwent detailed ultrasound
abdomen and pelvis study for the presence of PCOS. Among the 54
female children, Ultra sound study was normal in 52 girls (96.30%)
and 2 girls (3.70%) had PCOS.
 HbA1c test was performed for all the 140children included in
the study. The study population was categorised into 3 groups
based on the HbA1c level. HbA1c level < 5.6 as normal category,
HbA1c level 5.7 to 5.9 as prediabetes category and HbA1c level > 6
as diabetic category.
Among the 140 children screened for T2DM 136 children
(97.14%) were normal, 4 children (2.86%) were diagnosed to have
prediabetes.
Among the 136 children categorised as normal (HbA1c ? 5.6
category) 43 children (31.62%) were aged between 10-12 years, 30
children (22.06%) were aged between 13-15 years and 16 children
(46.32%) were aged between 16-19 years.
Among the 4 children categorised as Pre diabetic (HbA1c 5.7
to 5.9 ), 2 children (50%), belonged to Age group 10-12, 1  children
(25%) belonged to Age group 13-15 and 1 children (25%) belonged
to Age group 16-19 years.
Among the 136 children with normal HbA1c level 85
(98.84%) were Male and 51 (94.44%) were Female. Among the 4
children with HbA1c 5.7 to 5.9 (Prediabetes children) the number
of Male and Female was 1 (1.16%) and 3 (5.56%) respectively.
Among the 136 children with normal HbA1c ? 5.6 level 40
(29.41%) children were under weight, 79 (58.09%) children were
Normal weight and 17 (12.5%) children were Overweight.The
number of Normal and Overweight children diagnosed in
prediabetes category i.e. HbA1c 5.7 to 5.9  was 3 (75%) and 1
(25%) respectively. Among the 4 children diagnosed in prediabetes
category underweight children was nil (0).
Among the 52 female children with normal ultrasound scan
study 50 children had normal HbA1c level ? 5.6 and 2 female
children with normal USG scan study was found to have HbA1c >
5.6 and diagnosed as prediabetes child. Among the 2 female
children who were found to have PCOS on USG, one child have
normal HbA1c level <5.6 and 1child have HbA1c >5.6 and
diagnosed as prediabetes child.
COMPARISON OF OUR STUDY WITH OTHER PREVIOUS
STUDIES:
In Bhatia, et al. study (6) T2DM accounted for 12% of cases
(total 160 cases) in children below 18 years of age. In our study
Prediabetes accounted for 2.86% of cases (total 140 cases) in
children below 16 years of age.
Ranjani et al study  (39) did a study in children aged 12 to 19
years for prediabetes screening. In their study  the overall
prevalence of pre-diabetes was 3.7% and pre-diabetics  in girls was
4.2%  and 3.2% of boys were prediabetic. In our study the overall
prevalence of pre-diabetes in children and adolescents aged 10-
16years was 2.86% and the prevalence of pre-diabetes among the
girls with high risk factors was 5.56% and in boys was 1.16%.
In our study prediabetes is more common in girls than boys
and this difference may be due to the hormonal changes which are
more rapid in females than males.
In a study conducted by Chaoyang et al (40) in U.S.
adolescents the prevalence of pre-diabetes among those with
positive family history of diabetes was 25%, while in our study the
prevalence of pre-diabetes among those with positive family history
of diabetes was 100 %. The prevalence was 100% in our study
since we conducted the study in children of T2DM parents.
In a study conducted by Kaur et al study (41)18.2% of obese
children had pre-diabetes (impaired glucose tolerance). In our study
25% of overweight children had pre-diabetes.
Ramachandran, et al (5) reported 18 children below the age
of 15 years (5 boys and 13 girls) with T2DM diagnosed. 9 were
obese and were asymptomatic and picked up on screening which
was performed due to strong family history of DM. In our study we
reported 4 children below the age of 15 years (1 boy and 3 girls)
with prediabetes diagnosed. All these prediabetic children were
asymptomatic and picked up on screening which was performed due
to strong family history of DM. Among these 4 prediabetes children
1 child was overweight.
 In a screening study conducted by Reinher et al (22) the
prevalence of T2DM in obese children was 0.4 % to 1%. In our
study the prevalence of prediabetes in overweight children of
T2DM parents was 25%
Elham Al Amiri et al study (42) estimated the prevalence of
prediabetes and type 2diabetes among 1034 overweight/obese
children and adolescents aged 11–17 years. Capillary fasting blood
glucose (FBG) and glycated hemoglobin (HbA1c) were measured
by finger prick test, followed by confirmatory oral glucose
tolerance tests (OGTT). The median age of the study population
was 14.7 years. They reported prevalence of prediabetes in 21.9 %
of the children using the HbA1c criteria 5.7 – 6.4 % for
prediabetes. In our study 140 children aged 10 -19 years were
screened for diabetes and prediabetes by using HbA1c criteria as
recommended by ADA. We collected venous sample for HbA1c
test. Prevalence of prediabetes in adolescents aged 10-16years with
high  risk  factors  for  T2DM  was  2.86% and the prevalence of
prediabetes in overweight children was 25%.
In a epidemiological study conducted by Fagot-Campagna A
et al (43) Acanthosis nigricans was present in 90% of children and
adolescents with T2DM in North America. In our study Acanthosis
nigricans was present in 11.1% of children and adolescents with
pre-diabetes.
 In Jinan B saddine et al (36) study mean age of the study
population was 15years.The majority of the study population were
males (49%). 11% of the participants were overweight. The mean
HbA1c level was 4.99. The statistically highest mean HbA1c level
was found in the participants aged 10-14years, male and overweight
participants.
In our study mean age of the study population was 14.5 years
years. The majority of the study populations were males (61.43%).
12.86% of the participants were overweight. The mean HbA1c level
was 4.9± 0.31 which correlated with Jinan B saddine et al study.
Variations of HbA1c level with specific age and sex group was
analysed statistically but the differences in HbA1c level and
specific age and sex group was not statistically significant which is
not correlated with Jinan B saddine et al(36)  study. This may be
due to the less number of study population in our study(7974
children, adolescents, adults in Jinan B saddine et al (36) and only
140 children and adolescents in our study).
 In our study we found a statistically significant higher
HbA1c in female children with PCOS than their counterparts (P
value < 0.005). This significant difference may be due to the
presence of insulin resistance in PCOS children associated with
High HbA1c level.
To conclude the discussion all the 4 children (2.86%) who
were diagnosed to have prediabetes based on the high HbA1c level
>5.6 to 5.9 category had one or more risk factors for T2DM such as
family history of diabetes or with signs of insulin resistance like
overweight or PCOS or Acanthosis nigricans.
HbA1c test can be used as screening test to detect prediabetes
and diabetes in high risk children having family history of diabetes
with one or more risk factors for T2DM like overweight /obesity
/Acanthosis nigricans /PCOS. By early screening at young age
group we can prevent diabetes related complications. HbA1c test
can also be used to diagnose diabetes in the prediabetic stage itself
so that we can implement preventive strategies to halt the
progression of pre-diabetes to diabetes.
CONCLUSIONS
1. Targeted screening of children and adolescents with risk
factors for Type 2 diabetes by HbA1c test is justified in many
studies and in our study.
2. By early screening for diabetes in children of T2DM parents,
we can prevent Type 2 diabetes related morbidity and
mortality.
3. Identification of type 2 diabetes in the asymptomatic children
in the pre-diabetic stage itself  by HbA1c analysis must be
encouraged in the paediatric practice.
4. Early screening and diagnosis of type 2 diabetes mellitus
should be one of the main targets of public health
intervention programs.
5. Pediatricians should make the public aware of both the
childhood obesity epidemic and its serious consequences of
type 2 diabetes mellitus.
LIMITATIONS OF THE STUDY
Our study analyzed only the prevalence of pre diabetes in
children and adolescents of T2DM parents using HbA1c test as a
screening test.
In our study we included 140 subjects as sample size which
was small to make comparisons and to draw conclusions for the
general population.
Hence large scale studies are needed to know the accurate
prevalence of diabetes in children and adolescents among general
population.
RECOMMENDATIONS
Targeted screening in apparently asymptomatic children and
adolescents presenting with risk factors for T2DM like
positive family history of diabetes or obesity or PCOS or
acanthosis nigricans or hypertension is needed.
HbA1c can be used as the choice of the method for screening
due to high the levels of sensitivity and specificity compared
to Fasting Plasma Glucose.
Health authorities and professional organisations should
formulate policies concerning screening for type 2 diabetes.
Awareness program for prevention of T2DM in the young
population should be initiated.
Lifestyle modification & Daily physical activity to prevent
overweight/obesity should be stressed for all children
particularly those with risk factors for T2DM.
Regular follow up with appropriate screening test is
important for at risk children and adolescents for T2DM to
prevent the diabetes development and its complications.
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PATIENT CONSENT FORM
Study Detail : Screening Children of Type 2 Diabetes
Mellitus Parents

PROFORMA
Screening Children of Type 2 Diabetes Mellitus Parents
Sl.No:
Name:                                Age:                  Sex:
Address:                                                     OP.No:
Phone No:
Parent’s Details:
Details Age Diabetic or
Non
Diabetic
Age
Onset
Duration Oral
Drugs/
Insulin
Father
Mother
Children
Children’s details:
1. Height:                2.Weight:
3. BMI    :  Underweight / Normal /Overweight / Obese
Physical Examination:
1. Acanthosis Nigricans:  present / not
2. Blood pressure         :   normal/ increased
3. PCOD by USG                 :
4. HBA1C level                 :
ABBREVATION
ADA - American Diabetes association
T2DM   - Type 2 Diabetes Mellitus
T1DM   - Type 1 Diabetes Mellitus
BMI - Body Mass Index
FPG - Fasting Plasma Glucose
IFG - Impaired Fasting Glucose
IGT - Impaired Glucose Tolerance
NIDDM  - Non-Insulin Dependent Diabetes Mellitus
IAP - Indian Academy of Pediatrics
NCD - Non Communicable Disease
OGTT - Oral Glucose Tolerance Test
WHO - World Health Organization
11
S No Name Age Sex
Parents Diabetic
Status BP(M
m Hg)
Height
(Cm) Weight(Kg) BMI
Acanthosis
Nigricans USG(Female) HBA1C
Mother Father
1 Monica 10 F Yes No 90/70 131 35 20.4 No Normal study 4.6
2 Monish 10 M Yes No 100/70 130 25 14.79 No - 4.2
3 Jagadeshwaran 11 M Yes No 90/70 141 43 21.71 No - 4.8
4 Paramesh 11 M No Yes 100/70 140 40 20.4 Yes - 5.1
5 Renuga devi 12 F No Yes 100/70 158 57 22.89 No Normal study 4.7
6 Sanjay 15 M No Yes 100/70 165 42 15.44 No - 5.1
7 Nasrren 12 F No Yes 100/70 160 68 26.56 Yes Prominent
ovaries/PCOD
5.2
8 Kalaiselvi 10 F Yes No 90/70 140 33 16.8 Yes Normal study 4.5
9 Meena 14 F Yes No 100/70 150 35 15.55 No Normal study 4.8
10 Saradha 18 F No Yes 110/70 164 52 19.4 No Normal study 5.2
11 Aishwarya 10 F No Yes 100/70 142 40 19.9 Yes Prominent
ovaries/PCOD
5.4
12 Guruprasad 17 M No Yes 110/70 165 52 19.11 No - 5.1
13 Mubin 17 M No Yes 100/70 162 54 20.61 No - 4.4
14 Afridi 16 M No Yes 100/70 158 49 19.67 No - 4.7
15 Vignesh 17 M No Yes 110/70 165 58 21.32 No - 4.7
16 Lokesh 16 M No Yes 100/70 162 53 20.22 No - 4.6
17 Vignesh 18 M Yes No 110/70 165 68 26.32 No - 4.7
18 Priya 16 F No Yes 90/70 158 49 19.67 No Normal study 5.1
19 Keerthana 14 F No Yes 90/70 154 46 19.4 No Normal study 5.8
20 Tamil mani 17 M No Yes 100/70 162 54 20.61 No - 5.1
21 Lavanya 14 F No Yes 100/70 154 46 19.4 No Normal study 4.5
22 Santhosh 10 M Yes No 100/70 140 48 24.4 No - 4.6
11
S No
Name Age Sex
Parents Diabetic
Status BP(M
m Hg)
Height(
Cm)
Weight
(Kg) BMI
Acanthosis
Nigricans USG(Female) HBA1C
Mother Father
23 Santhiya 11 F Yes No 100/70 133 36 20.45 No Normal study 4.5
24 Dharanidharan 10 M No Yes 90/70 136 30 16.3 No - 4.1
25 Anand 17 M No Yes 110/70 161 50 19.3 No - 4.9
26 Gautam 15 M No Yes 90/70 157 39 15.85 No - 5.2
27 Santhosh 13 M No Yes 90/70 150 34 15.11 No - 5.1
28 Magendra
kumar
11 M No Yes 90/70 138 35 18.42 No - 4.4
29 Sanjay 18 M No Yes 110/70 165 56 20.58 No - 4.8
30 Vishal 18 M Yes No 100/70 160 49 19.14 No - 4.9
31 Naveen 16 M Yes No 90/70 152 42 18.18 No - 5.1
32 Irfan 15 M Yes No 100/70 152 40 17.31 No - 4.9
33 Reshma 12 F Yes No 90/70 144 36 17.39 No Normal study 4.6
34 Fathima 10 F Yes No 90/70 135 29 15.9 No Normal study 4.5
35 Dhanush 11 M Yes No 90/70 138 34 17.89 No - 4.2
36 Gokul 18 M No Yes 100/70 159 46 18.25 No - 5.2
37 Rahul 13 M No Yes 100/70 146 36 16.9 No - 4.4
38 Velan 18 M Yes No 100/70 160 49 19.14 No - 4.7
39 Kowsalya 16 F Yes No 100/70 152 44 19.04 No Normal study 4.2
40 Manivannan 18 M No Yes 100/70 159 42 16.66 No - 5.1
41 Malarvizhi 17 F No Yes 100/70 160 45 17.57 No Normal study 4.9
42 Madhu 16 F No Yes 100/70 158 43 17.26 No Normal study 4.6
43 John roshan 18 M No Yes 100/70 172 56 18.98 Yes - 5.2
44 Janani 10 F No Yes 90/70 123 22 14.6 No Normal study 4.9
45 Priyadharshini 12 F No Yes 100/70 144 46 22.3 Yes Normal study 5.4
11
S No
Name Age Sex
Parents Diabetic
Status BP(M
m Hg)
Height(
Cm)
Weight
(Kg) BMI
Acanthosis
Nigricans USG(Female) HBA1C
Mother Father
46 Sai kishore 10 M No Yes 110/80 144 50 25.5 Yes - 4.7
47 Sahara fathima 10 F No Yes 100/70 145 39 18.5 Yes Prominent
ovaries/PCOD
5.8
48 Elakiya 12 F Yes No 110/80 143 56 27.39 Yes Prominent
ovaries/PCOD
5.7
49 Lokesh 12 M No Yes 110/70 145 60 28.5 Yes - 5.6
50 Madhan 10 M No Yes 110/70 142 52 25.8 Yes - 4.7
51 Deepak 18 M No Yes 110/70 161 58 22.4 No - 5.1
52 Irfan 12 M No Yes 110/70 147 42 19.4 Yes - 4.9
53 Mohanraj 18 M Yes No 110/70 167 43 16.4 No - 5.2
54 Ramya 18 F Yes No 110/70 165 49 18.4 No Normal study 5.1
55 Dhanush 13 M Yes No 95/60 146 28 14.8 No - 5
56 Harish 12 M Yes No 90/60 142 29 15.4 No - 5.1
57 Divya 19 F Yes No 100/70 169 43 15.6 No Normal study 4.9
58 Rohith 11 M Yes No 110/70 157 69 28 Yes - 4.9
59 Saranraj 13 M No Yes 90/70 154 42 17.8 No - 4.8
60 Madhan 17 M No Yes 120/80 164 49 18.2 No - 5.1
61 Malathi 18 F No Yes 105/70 154 44 18.6 No Normal study 5.2
62 Venkatesh 19 M Yes No 110/70 165 55 20.2 No - 5.2
63 Manikandan 17 M Yes No 110/70 163 54 20.3 No - 5.1
64 Tamilarasan 18 M Yes No 110/70 163 52 19.6 No - 4.9
65 Tamil selvi 19 F Yes No 110/70 157 49 20 No Normal study 4.8
66 Yokesh 10 M No Yes 110/70 130 30 17.7 No - 5.1
67 Dharani 12 F No Yes 110/70 148 63 28.8 No Simple right
Ovarian cyst
4.7
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68 Asina afreen 12 F Yes No 110/70 163 61 23 No Normal study 4.9
69 Divya bharathi 12 F No Yes 90/70 152 50 21.6 No Normal study 4.8
70 Nandhini 10 F No Yes 100/80 142 50 24.8 Yes Normal study 5
71 Vaishali 11 F Yes No 110/80 146 55 25.8 Yes Normal study 4.8
72 Nandhini 17 F Yes No 110/70 151 37 16.2 No Normal study 5.1
73 Jesima 16 F Yes No 110/70 159 45 17.8 No Normal study 5
73 Santhiya 13 F Yes No 110/70 152 64 27.7 Yes Normal study 5.3
75 Safna fathima 10 F No Yes 110/70 150 50 22.2 Yes Normal study 4.9
76 Deepalakshmi 10 F Yes No 110/70 169 47 24.3 No Normal study 4.6
77 Nithish kumar 12 M Yes Yes 120/70 163 70 26.3 Yes - 4.6
78 Ajay calvin 10 M No Yes 100/60 130 37 21 Yes - 4.9
79 Shireen 18 F Yes No 110/70 163 60 22.6 No Normal study 5
80 Saran raj 13 M No Yes 100/70 147 38 17.6 No - 4.7
81 Sanjay 10 M No Yes 90/70 139 36 18.6 No - 4.9
82 Rasheeka 12 F Yes No 90/70 146 40 18.8 No Normal study 4.8
83 Nandhini 18 F Yes Yes 100/70 158 49 19.6 No Normal study 5.1
84 Naveen kumar 12 M Yes Yes 90/70 144 36 17.4 No - 4.7
85 Ramya 18 F Yes No 90/70 163 50 18.8 No Normal study 5.1
86 Mohanraj 17 M Yes No 110/70 165 52 19.1 No - 4.8
87 Prasanna 18 M No Yes 100/70 164 54 20.1 No - 5
88 Sridharan 15 M No Yes 100/70 156 42 17.3 No - 4.9
89 Ashwin 18 M Yes No 100/70 165 49 18 No - 4.6
90 Dhanush 17 M Yes No 100/70 162 52 19.8 No - 4.6
91 Madhan 17 M No Yes 100/70 161 49 18.9 No - 5.1
92 Malathi 18 F No Yes 100/70 164 50 18.6 No Normal study 5.2
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93 Venugopal 16 M No Yes 100/70 162 51 19.4 No - 4.5
94 Kishore 11 M No Yes 90/70 142 36 17.9 No - 4.3
95 Nandhini 18 F Yes No 110/70 158 46 18.4 No Normal study 5.1
96 Divya 16 F Yes No 110/70 155 46.5 19.1 No Normal study 4.9
97 Sham kumar 15 M Yes No 100/70 157 44 17.9 No - 4.8
98 Divyashree 17 F Yes No 100/70 155 48 20 No Normal study 4.9
99 Prashanth 18 M Yes Yes 110/70 160 49 19.1 No - 5.1
100 Sai ananth 15 M Yes Yes 110/70 158 52 20.8 No - 5
101 Vaithiyalinga
m
17 M Yes No 110/70 165 53 19.5 No - 4.7
102 Vinayagam 15 M Yes No 110/70 159 50 19.8 No - 4.8
103 Rahul 17 M Yes Yes 110/70 162 54 20.6 Yes - 5.2
104 Dhanapal 18 M No Yes 100/70 164 52 19.3 No - 5
105 Raji 14 F No Yes 100/70 149 39 17.6 No Normal study 4.9
106 Kirubakaran 13 M No Yes 120/80 148 52 23.7 Yes - 4.9
107 Jeeva 14 M Yes No 100/70 159 50 19.8 No - 4.8
108 Jeevanantham 15 M Yes No 100/70 162 52 19.8 No - 4.9
109 Saranraj 13 M No Yes 100/70 156 48 19.7 No - 5
110 Sanjay 10 M No Yes 90/70 136 33 17.2 No - 4.7
111 Rashika 12 F Yes No 100/70 147 44 20.4 No Normal study 4.9
112 Gandhi 14 M No Yes 100/70 156 52 21.4 No - 4.9
113 Suganya 12 F No Yes 100/70 146 52 24.5 No Normal study 4.8
114 Mayilvahanan 16 M Yes No 110/70 162 56 21.3 No - 5.1
115 Raju 13 M Yes No 100/70 146 38 17.8 No - 4.8
116 Janiya sultana 17 F Yes No 100/70 159 49 19.4 No Normal study 5.1
11
117 Faizal 15 M Yes No 100/70 155 47 19.6 No - 4.9
S No
Name Age Sex
Parents Diabetic
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Acanthosis
Nigricans USG(Female) HBA1CMother Father
118 Ali ahamed 14 M No Yes 100/70 153 46 19.8 No - 4.8
119 Fathima 12 F No Yes 100/70 150 39 17.3 No Normal study 4.7
120 Kughan 17 M No Yes 100/70 163 54 20.3 No Normal study 5
121 Vishal 11 M Yes No 90/70 141 43 21.71 No - 5
122 Surya 15 M Yes No 100/70 151 48 19.7 No - 5.1
123 Manikandan 16 M Yes Yes 100/70 154 46 19.4 No - 5.1
124 Saravanan 13 M Yes Yes 100/70 146 42 19.7 No - 4.9
125 Venkatesh 18 M Yes No 110/70 165 55 20.02 No - 5.2
126 Mani 16 M Yes No 100/70 153 46 19.7 No - 4.9
127 Nilofar sharma 18 F Yes No 100/70 154 47 19.3 No Normal study 4.8
128 Prema 16 F Yes Yes 100/70 158 58 23.2 Yes Normal study 4.5
129 Dinesh 16 M No Yes 110/70 162 58 22.1 No - 4.6
130 Suresh 14 M No Yes 100/70 152 56 24.2 No - 5.4
131 Mohammed
ibrahim
17 M Yes Yes 110/70 162 60 22.9 No - 5.5
132 Noorjahan 15 F Yes Yes 100/70 156 70 28.8 Yes Normal study 4.8
133 Prema 17 F No Yes 110/70 160 66 25.8 Yes Normal study 4.5
134 Sathish 16 M No Yes 100/70 160 64 25 Yes - 4.9
135 Jeevan 15 M Yes Yes 100/70 156 62 25.5 No - 4.7
136 Nazir 16 M Yes Yes 100/70 162 64 24.4 Yes - 5.8
137 Muhil 10 F No Yes 90/70 134 40 22.3 No Normal study 4.9
138 Ramesh 15 M Yes Yes 100/70 152 59 25.5 No - 4.9
139 Abirami 17 F No Yes 100/70 158 70 28 No Normal study 5.3
140 Kavitha 16 F No Yes 100/70 149 56 25.2 Yes Normal study 4.6
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